Clinical trial
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal…
NCT00002529 · ETOP IBCSG Partners Foundation, Other · Completed
Key facts
| NCT number | NCT00002529 |
|---|---|
| Title | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer |
| Official title | Adjuvant Therapy for Post/Perimenopausal Patients With Node Positive Breast Cancer Who Are Suitable for Endocrine Therapy Alone. |
| Acronym | 12-93 |
| Lead sponsor | ETOP IBCSG Partners Foundation, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride, tamoxifen citrate, toremifene |
| Enrollment | 452 |
| Start date | May 1, 1993 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Jul 29, 2004 |
| Last update posted | Apr 4, 2013 |
| Countries | Australia, Italy, New Zealand, Slovenia, South Africa, Sweden, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: